XML 36 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement (Tables)
6 Months Ended
Sep. 30, 2013
Restatement of Prior Year Income [Abstract]  
Schedule of adjustments on balance sheet

Balance Sheet data September 30, 2013 
(unaudited)
 
  As previously 
restated
  Adjustments to Restate    Restated 
Total Assets $331,432  $-    $331,432 
               
Derivative liability  49,995   1,752,664  (a)  1,802,659 
               
Total Current Liabilities  1,668,447   1,752,664     3,421,111 
Total Liabilities  1,711,422   1,752,664     3,464,086 
               
Stockholders’ Equity:              
Common stock, $.001 par value; 495,000,000 shares authorized; 87,551,493 and 83,651,493 shares issued and outstanding as of September 30, 2013 and March 31, 2013, respectively  87,552   -     87,552 
Additional paid-in capital  2,349,021   (593,228) (b)  1,755,793 
Common stock to be issued  51,125   -  -  51,125 
Deficit accumulated during development stage  (3,867,688)  (1,159,436) (a)(b)  (5,027,124)
Total Stockholders’ deficit  (1,379,990)  (1,752,664)    (3,132,654)
Total Liabilities and Stockholders’ deficit $331,432  $-    $331,432 

 

(a)

To increase the derivative liability.

 

(b)To adjust for incorrect accounting for beneficial conversion feature and derivative instruments.
Schedule of adjustments on statement of operations

 

Statement of operations 

For the Three Months Ended

September 30, 2013

(Unaudited)

  

For the Six Months Ended

September 30, 2013

(Unaudited)

 
 As previously restated  Adjustments to Restate    Restated  As previously restated  Adjustments to Restate    Restated 
                             
Loss from operation $630,441  $(12,244) (a) $618,197  $744,795  $(12,244) (a) $732,551 
Other expenses  946,022   1,171,680  (b)  2,117,702   952,183   1,171,680  (b)  2,123,863 
Net loss $1,576,463  $1,159,436  (a)(b) $2,735,899  $1,696,978  $1,159,436  (a)(b) $2,856,414 

  

(a)

To correct value of compensation warrants.

 

(b)To record $1,381,781 of expense related to the issuance of derivative instruments and $210,101 of income related to the change in fair value.